Author:
Hasegawa Yuto,Kim Juhyun,Ursini Gianluca,Jouroukhin Yan,Zhu Xiaolei,Miyahara Yu,Xiong Feiyi,Madireddy Samskruthi,Obayashi Mizuho,Lutz Beat,Sawa Akira,Brown Solange P.,Pletnikov Mikhail V.,Kamiya Atsushi
Abstract
AbstractAdolescent cannabis use increases the risk for cognitive impairments and psychiatric disorders. Cannabinoid receptor type 1 (Cnr1) is expressed not only in neurons and astrocytes, but also in microglia, which shape synaptic connections during adolescence. Nonetheless, until now, the role of microglia in mediating the adverse cognitive effects of delta-9-tetrahydrocannabinol (THC), the principal psychoactive constituent of cannabis, has been unexplored. Here, we report that adolescent THC exposure produces microglial apoptosis in the medial prefrontal cortex (mPFC), which was exacerbated in the mouse model of 16p11.2 duplication, a representative copy number variation (CNV) risk factor for psychiatric disorders. These effects are mediated by microglial Cnr1, leading to reduction in the excitability of mPFC pyramidal-tract neurons and deficits in social memory in adulthood. Our findings highlight the importance of microglial Cnr1 to produce the adverse effect of cannabis exposure in genetically vulnerable individuals.
Publisher
Cold Spring Harbor Laboratory